{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T16:46:53Z","timestamp":1788281213750,"version":"build-2803163510"},"reference-count":24,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,11,28]],"date-time":"2023-11-28T00:00:00Z","timestamp":1701129600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["World Neurosurgery: X"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1016\/j.wnsx.2023.100253","type":"journal-article","created":{"date-parts":[[2023,12,5]],"date-time":"2023-12-05T02:32:33Z","timestamp":1701743553000},"page":"100253","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"special_numbering":"C","title":["Initial real-world experience of clazosentan for subarachnoid hemorrhage in Japan"],"prefix":"10.1016","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8852-0208","authenticated-orcid":false,"given":"Takuma","family":"Maeda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mai","family":"Okawara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manabu","family":"Osakabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroyuki","family":"Yamaguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takahiro","family":"Maeda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroki","family":"Kurita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.wnsx.2023.100253_bib1","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1007\/s10143-006-0045-5","article-title":"Comparison between clipping and coiling on the incidence of cerebral vasospasm after aneurysmal subarachnoid hemorrhage: a systematic review and meta-analysis","volume":"30","author":"de Oliveira","year":"2007","journal-title":"Neurosurg Rev"},{"key":"10.1016\/j.wnsx.2023.100253_bib2","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1161\/STR.0b013e3182587839","article-title":"Guidelines for the management of aneurysmal subarachnoid hemorrhage: a guideline for healthcare professionals from the American Heart Association\/American Stroke Association","volume":"43","author":"Connolly","year":"2012","journal-title":"Stroke"},{"key":"10.1016\/j.wnsx.2023.100253_bib3","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/j.wneu.2019.03.083","article-title":"A review of the management of cerebral vasospasm after aneurysmal subarachnoid hemorrhage","volume":"126","author":"Li","year":"2019","journal-title":"World Neurosurg"},{"key":"10.1016\/j.wnsx.2023.100253_bib4","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1007\/s40265-022-01708-0","article-title":"Clazosentan: first approval","volume":"82","author":"Lee","year":"2022","journal-title":"Drugs"},{"key":"10.1016\/j.wnsx.2023.100253_bib5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1152\/physrev.00060.2009","article-title":"Regulation of blood pressure and salt homeostasis by endothelin","volume":"91","author":"Kohan","year":"2011","journal-title":"Physiol Rev"},{"key":"10.1016\/j.wnsx.2023.100253_bib6","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.3171\/2022.2.JNS212914","article-title":"Effects of clazosentan on cerebral vasospasm\u2013related morbidity and all-cause mortality after aneurysmal subarachnoid hemorrhage: two randomized phase 3 trials in Japanese patients","volume":"137","author":"Endo","year":"2022","journal-title":"J Neurosurg"},{"key":"10.1016\/j.wnsx.2023.100253_bib7","doi-asserted-by":"crossref","first-page":"1963","DOI":"10.1161\/STROKEAHA.108.544700","article-title":"Defining vasospasm after subarachnoid hemorrhage: what is the most clinically relevant definition?","volume":"40","author":"Frontera","year":"2009","journal-title":"Stroke"},{"key":"10.1016\/j.wnsx.2023.100253_bib8","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1001\/jamaneurol.2021.4346","article-title":"Twenty-year change in severity and outcome of ischemic and hemorrhagic strokes","volume":"79","author":"Toyoda","year":"2022","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.wnsx.2023.100253_bib9","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1001\/jamaneurol.2019.0006","article-title":"Worldwide incidence of aneurysmal subarachnoid hemorrhage according to region, time period, blood pressure, and smoking prevalence in the population: a systematic review and meta-analysis","volume":"76","author":"Etminan","year":"2019","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.wnsx.2023.100253_bib10","doi-asserted-by":"crossref","first-page":"e419","DOI":"10.1016\/j.wneu.2020.07.189","article-title":"Clinical outcome of elderly patients with subarachnoid hemorrhage: validation of modality assignment based on aneurysmal morphology and location","volume":"143","author":"Maeda","year":"2020","journal-title":"World Neurosurg"},{"key":"10.1016\/j.wnsx.2023.100253_bib11","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/0014-2999(94)90273-9","article-title":"Evidence for the formation of endothelin by lysed red blood cells from endogenous precursor","volume":"271","author":"Tippler","year":"1994","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.wnsx.2023.100253_bib12","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1161\/01.STR.25.4.904","article-title":"Does endothelin-1 play a role in the pathogenesis of cerebral vasospasm?","volume":"25","author":"Cosentino","year":"1994","journal-title":"Stroke"},{"key":"10.1016\/j.wnsx.2023.100253_bib13","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1097\/00006123-200212000-00002","article-title":"Endothelin receptor antagonists and cerebral vasospasm: an update","volume":"51","author":"Chow","year":"2002","journal-title":"Neurosurgery (Baltim)"},{"key":"10.1016\/j.wnsx.2023.100253_bib14","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1016\/S0022-3565(24)37130-7","article-title":"Ro 61\u20131790, a new hydrosoluble endothelin antagonist: general pharmacology and effects on experimental cerebral vasospasm","volume":"283","author":"Roux","year":"1997","journal-title":"J Pharmacol Exp Therapeut"},{"key":"10.1016\/j.wnsx.2023.100253_bib15","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/j.wneu.2018.10.213","article-title":"Clazosentan for aneurysmal subarachnoid hemorrhage: an updated meta-analysis with trial sequential analysis","volume":"123","author":"Cho","year":"2019","journal-title":"World Neurosurg"},{"key":"10.1016\/j.wnsx.2023.100253_bib16","doi-asserted-by":"crossref","first-page":"571","DOI":"10.3171\/jns.1992.76.4.0571","article-title":"Effect of AT877 on cerebral vasospasm after aneurysmal subarachnoid hemorrhage. Results of a prospective placebo-controlled double-blind trial","volume":"76","author":"Shibuya","year":"1992","journal-title":"J Neurosurg"},{"key":"10.1016\/j.wnsx.2023.100253_bib17","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1227\/01.NEU.0000156644.45384.92","article-title":"Prediction of cerebral vasospasm in patients presenting with aneurysmal subarachnoid hemorrhage: a review","volume":"56","author":"Harrod","year":"2005","journal-title":"Neurosurgery (Baltim)"},{"key":"10.1016\/j.wnsx.2023.100253_bib18","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1124\/jpet.116.234930","article-title":"Endothelin ETA receptor blockade, by activating ETB receptors, increases vascular permeability and induces exaggerated fluid retention","volume":"361","author":"Vercauteren","year":"2017","journal-title":"J Pharmacol Exp Therapeut"},{"key":"10.1016\/j.wnsx.2023.100253_bib19","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1172\/JCI8609","article-title":"Salt-sensitive hypertension in endothelin-B receptor-deficient rats","volume":"105","author":"Gariepy","year":"2000","journal-title":"J Clin Invest"},{"key":"10.1016\/j.wnsx.2023.100253_bib20","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1111\/j.1524-6175.2007.07244.x","article-title":"Efficacy and safety of darusentan in patients with resistant hypertension: results from a randomized, double-blind, placebo-controlled dose-ranging study","volume":"9","author":"Black","year":"2007","journal-title":"J Clin Hypertens"},{"key":"10.1016\/j.wnsx.2023.100253_bib21","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1681\/ASN.2009060593","article-title":"Avosentan for overt diabetic nephropathy","volume":"21","author":"Mann","year":"2010","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.wnsx.2023.100253_bib22","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.pupt.2017.08.002","article-title":"Effects of fasudil on pulmonary hypertension in clinical practice","volume":"46","author":"Zhang","year":"2017","journal-title":"Pulm Pharmacol Ther"},{"key":"10.1016\/j.wnsx.2023.100253_bib23","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1097\/ANA.0000000000000018","article-title":"Protocol for vasospasm","volume":"26","author":"Anand","year":"2014","journal-title":"J Neurosurg Anesthesiol"},{"key":"10.1016\/j.wnsx.2023.100253_bib24","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.121.021845","article-title":"Pathophysiology of delayed cerebral ischemia after subarachnoid hemorrhage: a review","volume":"10","author":"Dodd","year":"2021","journal-title":"J Am Heart Assoc"}],"container-title":["World Neurosurgery: X"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590139723001023?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590139723001023?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T06:00:05Z","timestamp":1778911205000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2590139723001023"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1]]},"references-count":24,"alternative-id":["S2590139723001023"],"URL":"https:\/\/doi.org\/10.1016\/j.wnsx.2023.100253","relation":{},"ISSN":["2590-1397"],"issn-type":[{"value":"2590-1397","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Initial real-world experience of clazosentan for subarachnoid hemorrhage in Japan","name":"articletitle","label":"Article Title"},{"value":"World Neurosurgery: X","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.wnsx.2023.100253","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"100253"}}